Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.

Beyond melting ice and higher temperatures: On Earth Day, scientists consider how climate change will affect national security.

PNNL has joined Gender Champions in Nuclear Policy, a leadership network that brings together leaders of organizations working in nuclear policy who are committed to breaking down gender barriers.

A team of Washington State University students delivered a project designed to improve preparation of environmental samples for analysis at PNNL.

Glenn Fugate was selected to serve on the American Chemical Society's Science Committee.

Germany Harris, Dewayne Maye, Sarah Olocha, Shaniya Pettway, and Rayonna Redmon became the first interns of the Minority Serving Institution Partnership Program Partnership for Radiation Studies Consortium at PNNL.

A team of researchers at PNNL designed and constructed an atmospheric chamber to simulate the fate of volatile and semivolatile radioisotopes.

Microbes that were previously frozen in soils are becoming more active. This study demonstrates the diverse RNA viral communities found in thawed permafrost.

New PNNL research makes it easier to differentiate between chemical and nuclear explosions.

Researchers at PNNL leveraged their experiences to connect with attendees at the 2022 SACNAS National Diversity in STEM Conference, October 27–29, 2022, in San Juan, Puerto Rico.

PNNL researchers use machine learning and data analytics to assist with detection of nuclear proliferation and nuclear material trafficking.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

PNNL experts in nuclear forensics helped lead laboratories around the world through a rigorous test involving nuclear materials.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Mary Lancaster, epidemiologist and data scientist, co-authored a chapter on cyberbiosecurity for the NATO Science for Peace and Security book series.

A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.